NEW YORK, July 6, 2016 /PRNewswire/ -- The Galien Foundation, the non-profit foundation that oversees and directs activities in the United States for the Prix Galien, an international award that recognizes outstanding achievements in improving the human condition through the development of innovative health advances, announced that it has engaged Finn Partners to help strengthen industry awareness of the Galien Foundation Medical Technology category.
"Medical technology has been advancing at an astounding pace. Many innovations have impacted the way in which we practice medicine and empower patients to be partners in their care," said Bruno Cohen, Chairman of the Galien Foundation. "Medical advances in the clinic are now being complemented with smart technologies and, therefore, we place equal emphasis on recognizing the innovators in health technology. Finn Partners, one of the the world's fastest growing PR agencies, brings a passion for our mission and broad knowledge of the medical technology industry."
The Prix Galien was created in France in 1970 by a pharmacist named Roland Mehl to promote significant advances in Biopharmaceutical research and recognize the achievements of the best research teams in the pharmaceutical field. The Prix Galien USA Awards and Forum launched in New York City in 2007, first honoring unique medical products, later devices, and individuals who have impacted patient care through innovation.
The Prix Galien Award Selection Committee, led by Dr. Roy Vagelos comprises numerous Nobel Prize Laureates and The Foundation board includes business leaders of note. The late Professor Elie Wiesel, a founding board member, served as honorary chair and held responsibility for bestowing of the Pro Bono Humanum Award recognizing an individual's outstanding efforts to improving the human condition. His presence and spirit will continue as a guiding influence as Professor Wiesel has been named Founding Honorary President Elie Wiesel.
"We are honored to help the Galien Foundation champion technological developments that place patients' needs at the center of care," said Kristen Berry, associate vice president, Health, Finn Partners and team lead for the account. "This is a rewarding opportunity to further the national dialogue around scientific innovation, access to care and encourage the free exchange of ideas and learnings."
The Prix Galien USA Awards ceremony will take place at the American Museum of Natural History in New York on Thursday, October 27, 2016. At that gathering, achievement of pharmaceutical, biotech, medical technology and individual achievement honors will be announced.
About the Galien Foundation
The Galien Foundation fosters, recognizes and rewards excellence in scientific innovation to improve the state of human health. Our vision is to be the catalyst for the development of the next generation of innovative treatment and technologies that will impact human health and save lives.
The Foundation oversees and directs activities in the USA for the Prix Galien, an international award that recognizes outstanding achievements in improving the human condition through the development of innovative therapies. The Prix Galien was created in France in 1970 in honor of Galen, the father of medical science and modern pharmacology. Worldwide, the Prix Galien is regarded as the equivalent of the Nobel Prize in biopharmaceutical and medical technology research.
For more information, visit www.galienfoundation.org.
About Finn Partners, Inc.
Finn Partners was launched in late 2011 to realize Peter Finn's vision to create a leading communications agency dedicated to shaping a bold new future in which innovation and partnership are strong brand drivers. Finn Partners specializes in the full spectrum of public and corporate affairs services, including digital and social media. Practice areas include arts, consumer, CSR, education, health, technology and travel & lifestyle.
Since inception four years ago, Finn Partners has received six agency awards that are indicators of client and cultural leadership: "Best Midsize Agency" in 2015, "Best Agency to Work For" in 2013 and "Best New Agency" in 2012 from the Holmes Report and "Midsize PR Firm of the Year" in 2015 and "Top Places to Work in PR" in 2013 from PR News. Headquartered in New York City, the company has approximately 500 employees, with offices in Chicago, Detroit, Fort Lauderdale, Jerusalem, London, Los Angeles, Munich, Nashville, Paris, San Francisco and Washington D.C., and offers international capabilities through its own global network and PROI Worldwide. Find us at www.finnpartners.com and follow us on Twitter @finnpartners.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/the-galien-foundation-enlists-finn-partners-to-promote-the-prix-galien-usa-awards-medical-technology-category-300294676.html
SOURCE Finn Partners